title: Investigations into the prevention of prenatal and lactogenic Toxocara canis infections in puppies by application of moxidectin to the pregnant dog.
abstract: Aim of the investigation was to examine whether two administrations of moxidectin to pregnant dogs could prevent pre-natal and lactogenic infections of puppies with reactivated Toxocara canis larvae. Four pregnant beagles, infected experimentally with 20 000 embryonated eggs of T. canis, were treated subcutaneously with 1 mg moxidectin per kg body weight on days 40 and 55 of pregnancy (5-13 days before parturition). One further dam and its puppies served as untreated control. Two applications of moxidectin completely prevented pre-natal and lactogenic infections in the puppies. Neither intestinal stages nor somatic larvae were found in the dams or their corresponding puppies. All puppies and dams of the treatment group remained coproscopically negative until 42 days after parturition. The administration of moxidectin did not show any side effects in the dams. None of the puppies of the treated dams showed any pathological abnormalities. In the untreated dam one adult and 26 somatic larvae of T. canis were detected at necropsy. All puppies of the untreated dam showed a patent T. canis infection from day 28 post-natum (p.n.); 296 pre-adult and adult stages of T. canis were spontaneously eliminated and 51 intestinal stages and five somatic larvae of T. canis were recovered at necropsy. In contrast to the puppies of the treated dams all negative control puppies showed blood eosinophilia after parturition and elevated liver enzyme levels.
authors.affiliation: Institute for Parasitology, University of Veterinary Medicine Hannover Foundation, Germany.
authors.forename: F
authors.initials: F
authors.lastname: Krämer
authors.forename: R
authors.initials: R
authors.lastname: Hammerstein
authors.forename: M
authors.initials: M
authors.lastname: Stoye
authors.forename: C
authors.initials: C
authors.lastname: Epe
mesh_terms: D000818:Animals; D000871:Anthelmintics / Q000008:administration & dosage* / Q000009:adverse effects; D004283:Dog Diseases / Q000517:prevention & control* / Q000635:transmission; D004285:Dogs; D005243:Feces / Q000469:parasitology; D005260:Female; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control / Q000662:veterinary*; D007774:Lactation; D018942:Macrolides / Q000008:administration & dosage / Q000009:adverse effects; D011247:Pregnancy; D011897:Random Allocation; D017166:Toxocara canis / Q000187:drug effects* / Q000254:growth & development; D014120:Toxocariasis / Q000517:prevention & control* / Q000635:transmission
chemical_list: D000871:Anthelmintics; D018942:Macrolides; C027837:moxidectin